View in EDS

460eTiP TELESCOPE: Neoadjuvant phase II study of pembrolizumab, carboplatin, and paclitaxel for stage I triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: 460eTiP TELESCOPE: Neoadjuvant phase II study of pembrolizumab, carboplatin, and paclitaxel for stage I triple-negative breast cancer.
Authors: Gion, M.1 (AUTHOR), Llombart Cussac, A.2 (AUTHOR), Perez Garcia, J.M.3 (AUTHOR), Blancas López-Barajas, I.4 (AUTHOR), Rea, A.5 (AUTHOR), Fazal Salom, J.6 (AUTHOR), Guerrero, J.A.7 (AUTHOR), Pitrelli Vazquez, N.8 (AUTHOR), Martinez Bueno, A.9 (AUTHOR), Reboredo Rendo, C.10 (AUTHOR), Zamora Adelantado, E.11 (AUTHOR), García Saenz, J.Á.12 (AUTHOR), Carnerero Córdoba, L.13 (AUTHOR), Ruiz Borrego, M.14 (AUTHOR), Palacios-Ozores, P.15 (AUTHOR), Vinas Villaro, G.16 (AUTHOR), De La Cruz, S.17 (AUTHOR), Carañana Ballerini, V.2 (AUTHOR), Cortés, J.C.18 (AUTHOR), Hurvitz, S.A.19 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS390-S391. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.883